Dimitrios Evangelopoulos - Publications

Affiliations: 
2014-2019 University College London, London, United Kingdom 

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Margaryan H, Evangelopoulos DD, Muraro Wildner L, McHugh TD. Pre-Clinical Tools for Predicting Drug Efficacy in Treatment of Tuberculosis. Microorganisms. 10. PMID 35336089 DOI: 10.3390/microorganisms10030514  0.316
2022 Frederickson M, Selvam IR, Evangelopoulos D, McLean KJ, Katariya MM, Tunnicliffe RB, Campbell B, Kavanagh ME, Charoensutthivarakul S, Blankley RT, Levy CW, de Carvalho LPS, Leys D, Munro AW, Coyne AG, et al. A new strategy for hit generation: Novel in cellulo active inhibitors of CYP121A1 from Mycobacterium tuberculosis via a combined X-ray crystallographic and phenotypic screening approach (XP screen). European Journal of Medicinal Chemistry. 230: 114105. PMID 35065413 DOI: 10.1016/j.ejmech.2022.114105  0.308
2021 Chetty S, Armstrong T, Sharma Kharkwal S, Drewe WC, De Matteis CI, Evangelopoulos D, Bhakta S, Thomas NR. New InhA Inhibitors Based on Expanded Triclosan and -Triclosan Analogues to Develop a New Treatment for Tuberculosis. Pharmaceuticals (Basel, Switzerland). 14. PMID 33919737 DOI: 10.3390/ph14040361  0.381
2020 Maitra A, Evangelopoulos D, Chrzastek A, Martin LT, Hanrath A, Chapman E, Hailes HC, Lipman M, McHugh TD, Waddell SJ, Bhakta S. Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis. The Journal of Antimicrobial Chemotherapy. PMID 32790867 DOI: 10.1093/Jac/Dkaa307  0.463
2020 Fenaroli F, Robertson JD, Scarpa E, Gouveia VM, Di Guglielmo C, De Pace C, Elks PM, Poma A, Evangelopoulos D, Ortiz Canseco J, Marriott HM, Dockrell DH, Foster S, McHugh TD, Renshaw SA, et al. Polymersomes Eradicating Intracellular Bacteria. Acs Nano. PMID 32515944 DOI: 10.1021/Acsnano.0C01870  0.428
2018 Danquah CA, Kakagianni E, Khondkar P, Maitra A, Rahman M, Evangelopoulos D, McHugh TD, Stapleton P, Malkinson J, Bhakta S, Gibbons S. Analogues of Disulfides from Allium stipitatum Demonstrate Potent Anti-tubercular Activities through Drug Efflux Pump and Biofilm Inhibition. Scientific Reports. 8: 1150. PMID 29348586 DOI: 10.1038/s41598-017-18948-w  0.409
2017 de Knegt GJ, Dickinson L, Pertinez H, Evangelopoulos D, McHugh TD, Bakker-Woudenberg IAJM, Davies GR, de Steenwinkel JEM. Assessment of treatment response by colony forming units, time to culture positivity and the molecular bacterial load assay compared in a mouse tuberculosis model. Tuberculosis (Edinburgh, Scotland). 105: 113-118. PMID 28610782 DOI: 10.1016/J.Tube.2017.05.002  0.336
2017 Ryan A, Polycarpou E, Lack NA, Evangelopoulos D, Sieg C, Halman A, Bhakta S, Eleftheriadou O, McHugh TD, Keany S, Lowe ED, Ballet R, Abuhammad A, Jacobs WR, Ciulli A, et al. Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach. British Journal of Pharmacology. PMID 28380256 DOI: 10.1111/Bph.13810  0.474
2017 Evangelopoulos D, Whittaker E, Honeyborne I, McHugh TD, Klein N, Shingadia D. Pediatric tuberculosis-human immunodeficiency virus co-infection in the United Kingdom highlights the need for better therapy monitoring tools: a case report. Journal of Medical Case Reports. 11: 52. PMID 28236807 DOI: 10.1186/S13256-017-1222-6  0.356
2016 Sabiiti W, Mtafya B, Kuchaka D, Azam K, Viegas S, Mdolo A, Farmer EC, Khonga M, Evangelopoulos D, Honeyborne I, Rachow A, Heinrich N, Ntinginya NE, Bhatt N, Davies GR, et al. Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settings. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 20: 1004-9. PMID 27393531 DOI: 10.5588/Ijtld.15.0951  0.381
2016 Brucoli F, Guzman JD, Basher MA, Evangelopoulos D, McMahon E, Munshi T, McHugh TD, Fox KR, Bhakta S. DNA sequence-selective C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates show anti-tubercular-specific activities. The Journal of Antibiotics. PMID 27168314 DOI: 10.1038/Ja.2016.43  0.378
2016 Maitra A, Bates S, Shaik M, Evangelopoulos D, Abubakar I, McHugh TD, Lipman M, Bhakta S. Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs. British Medical Bulletin. PMID 27151954 DOI: 10.1093/Bmb/Ldw019  0.429
2016 Honeyborne I, McHugh TD, Kuittinen I, Cichonska A, Evangelopoulos D, Ronacher K, van Helden PD, Gillespie SH, Fernandez-Reyes D, Walzl G, Rousu J, Butcher PD, Waddell SJ. Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy. Bmc Medicine. 14: 68. PMID 27055815 DOI: 10.1186/S12916-016-0609-3  0.387
2016 Bhakta S, Scalacci N, Maitra A, Brown AK, Dasugari S, Evangelopoulos D, McHugh TD, Mortazavi PN, Twist A, Petricci E, Manetti F, Castagnolo D. Design and synthesis of 1-((1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl)methyl)-4-methylpiperazine (BM212) and N-Adamantan-2-yl-N'-((E)-3,7-dimethyl-octa-2,6-dienyl)-ethane-1,2-diamine (SQ109) pyrrole hybrid derivatives: discovery of potent anti-tubercular agents effective against multi-drug resistant mycobacteria. Journal of Medicinal Chemistry. PMID 26907951 DOI: 10.1021/Acs.Jmedchem.6B00031  0.418
2015 Evangelopoulos D, da Fonseca JD, Waddell SJ. Understanding anti-tuberculosis drug efficacy: rethinking bacterial populations and how we model them. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. 32: 76-80. PMID 25809760 DOI: 10.1016/J.Ijid.2014.11.028  0.469
2015 Evangelopoulos D, McHugh TD. Improving the Tuberculosis Drug Development Pipeline Chemical Biology and Drug Design. 86: 951-960. PMID 25772393 DOI: 10.1111/Cbdd.12549  0.453
2015 Honeyborne I, Lipman MC, Eckold C, Evangelopoulos D, Gillespie SH, Pym A, McHugh TD. Effective anti-tuberculosis therapy correlates with plasma small RNA. The European Respiratory Journal. 45: 1741-4. PMID 25745052 DOI: 10.1183/09031936.00221214  0.316
2015 Guzman JD, Pesnot T, Barrera DA, Davies HM, McMahon E, Evangelopoulos D, Mortazavi PN, Munshi T, Maitra A, Lamming ED, Angell R, Gershater MC, Redmond JM, Needham D, Ward JM, et al. Tetrahydroisoquinolines affect the whole-cell phenotype of Mycobacterium tuberculosis by inhibiting the ATP-dependent MurE ligase. The Journal of Antimicrobial Chemotherapy. 70: 1691-703. PMID 25656411 DOI: 10.1093/Jac/Dkv010  0.464
2015 Hochfellner C, Evangelopoulos D, Zloh M, Wube A, Guzman JD, McHugh TD, Kunert O, Bhakta S, Bucar F. Antagonistic effects of indoloquinazoline alkaloids on antimycobacterial activity of evocarpine. Journal of Applied Microbiology. 118: 864-72. PMID 25604161 DOI: 10.1111/Jam.12753  0.41
2014 Zhao J, Evangelopoulos D, Bhakta S, Gray AI, Seidel V. Antitubercular activity of Arctium lappa and Tussilago farfara extracts and constituents. Journal of Ethnopharmacology. 155: 796-800. PMID 24955560 DOI: 10.1016/J.Jep.2014.06.034  0.365
2014 McGuigan C, Derudas M, Gonczy B, Hinsinger K, Kandil S, Pertusati F, Serpi M, Snoeck R, Andrei G, Balzarini J, McHugh TD, Maitra A, Akorli E, Evangelopoulos D, Bhakta S. ProTides of N-(3-(5-(2'-deoxyuridine))prop-2-ynyl)octanamide as potential anti-tubercular and anti-viral agents. Bioorganic & Medicinal Chemistry. 22: 2816-24. PMID 24690527 DOI: 10.1016/J.Bmc.2014.02.056  0.424
2014 Guzman JD, Mortazavi PN, Munshi T, Evangelopoulos D, McHugh TD, Gibbons S, Malkinson J, Bhakta S. 2-Hydroxy-substituted cinnamic acids and acetanilides are selective growth inhibitors of Mycobacterium tuberculosis Medchemcomm. 5: 47-50. DOI: 10.1039/C3Md00251A  0.48
2013 Shiu WK, Malkinson JP, Rahman MM, Curry J, Stapleton P, Gunaratnam M, Neidle S, Mushtaq S, Warner M, Livermore DM, Evangelopoulos D, Basavannacharya C, Bhakta S, Schindler BD, Seo SM, et al. A new plant-derived antibacterial is an inhibitor of efflux pumps in Staphylococcus aureus. International Journal of Antimicrobial Agents. 42: 513-8. PMID 24119569 DOI: 10.1016/J.Ijantimicag.2013.08.007  0.374
2013 Guzman JD, Evangelopoulos D, Gupta A, Birchall K, Mwaigwisya S, Saxty B, McHugh TD, Gibbons S, Malkinson J, Bhakta S. Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay. Bmj Open. 3. PMID 23794563 DOI: 10.1136/Bmjopen-2013-002672  0.486
2013 Munshi T, Gupta A, Evangelopoulos D, Guzman JD, Gibbons S, Keep NH, Bhakta S. Characterisation of ATP-dependent Mur ligases involved in the biogenesis of cell wall peptidoglycan in Mycobacterium tuberculosis. Plos One. 8: e60143. PMID 23555903 DOI: 10.1371/Journal.Pone.0060143  0.392
2013 Guzman JD, Evangelopoulos D, Gupta A, Prieto JM, Gibbons S, Bhakta S. Antimycobacterials from lovage root (Ligusticum officinale Koch). Phytotherapy Research : Ptr. 27: 993-8. PMID 22899555 DOI: 10.1002/Ptr.4823  0.388
2012 Kottakota SK, Evangelopoulos D, Alnimr A, Bhakta S, McHugh TD, Gray M, Groundwater PW, Marrs EC, Perry JD, Spilling CD, Harburn JJ. Synthesis and biological evaluation of purpurealidin E-derived marine sponge metabolites: aplysamine-2, aplyzanzine A, and suberedamines A and B. Journal of Natural Products. 75: 1090-101. PMID 22620987 DOI: 10.1021/Np300102Z  0.401
2012 Osman K, Evangelopoulos D, Basavannacharya C, Gupta A, McHugh TD, Bhakta S, Gibbons S. An antibacterial from Hypericum acmosepalum inhibits ATP-dependent MurE ligase from Mycobacterium tuberculosis. International Journal of Antimicrobial Agents. 39: 124-9. PMID 22079533 DOI: 10.1016/J.Ijantimicag.2011.09.018  0.425
2012 Markarian SA, Evangelopoulos D, Harutyunyan LR, Pepoyan EK, Guzman JD, McHugh TD, Bhakta S. The properties of solutions of isoniazid in water and dimethylsulfoxide Journal of Solution Chemistry. 41: 1462-1476. DOI: 10.1007/S10953-012-9883-7  0.307
2011 Evangelopoulos D, Cronin N, Daviter T, Sim E, Keep NH, Bhakta S. Characterization of an oxidoreductase from the arylamine N-acetyltransferase operon in Mycobacterium smegmatis. The Febs Journal. 278: 4824-32. PMID 21972977 DOI: 10.1111/J.1742-4658.2011.08382.X  0.32
2011 Guzman JD, Wube A, Evangelopoulos D, Gupta A, Hüfner A, Basavannacharya C, Rahman MM, Thomaschitz C, Bauer R, McHugh TD, Nobeli I, Prieto JM, Gibbons S, Bucar F, Bhakta S. Interaction of N-methyl-2-alkenyl-4-quinolones with ATP-dependent MurE ligase of Mycobacterium tuberculosis: antibacterial activity, molecular docking and inhibition kinetics. The Journal of Antimicrobial Chemotherapy. 66: 1766-72. PMID 21622974 DOI: 10.1093/Jac/Dkr203  0.476
2010 Guzman JD, Gupta A, Evangelopoulos D, Basavannacharya C, Pabon LC, Plazas EA, Muñoz DR, Delgado WA, Cuca LE, Ribon W, Gibbons S, Bhakta S. Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium tuberculosis. The Journal of Antimicrobial Chemotherapy. 65: 2101-7. PMID 20719764 DOI: 10.1093/Jac/Dkq313  0.5
2010 Evangelopoulos D, Bhakta S. Rapid methods for testing inhibitors of mycobacterial growth. Methods in Molecular Biology (Clifton, N.J.). 642: 193-201. PMID 20401596 DOI: 10.1007/978-1-60327-279-7_15  0.431
2009 O'Donnell G, Poeschl R, Zimhony O, Gunaratnam M, Moreira JB, Neidle S, Evangelopoulos D, Bhakta S, Malkinson JP, Boshoff HI, Lenaerts A, Gibbons S. Bioactive pyridine-N-oxide disulfides from Allium stipitatum. Journal of Natural Products. 72: 360-5. PMID 19093848 DOI: 10.1021/Np800572R  0.369
2009 Lack NA, Kawamura A, Fullam E, Laurieri N, Beard S, Russell AJ, Evangelopoulos D, Westwood I, Sim E. Temperature stability of proteins essential for the intracellular survival of Mycobacterium tuberculosis. The Biochemical Journal. 418: 369-78. PMID 19014350 DOI: 10.1042/Bj20082011  0.396
2008 Sim E, Sandy J, Evangelopoulos D, Fullam E, Bhakta S, Westwood I, Krylova A, Lack N, Noble M. Arylamine N-acetyltransferases in mycobacteria. Current Drug Metabolism. 9: 510-9. PMID 18680471 DOI: 10.2174/138920008784892100  0.357
Show low-probability matches.